Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441201 · ClinicalTrials.gov registry record
Acute Gastrointestinal Bleeding Peripheral Pulse Volume Changes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 13
- Enrollment target
NCT06441201: Completed study, sponsored by Mayo Clinic.
NCT06441201 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06441201 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
Interventions
- DIAGNOSTIC_TEST Pulse flowmeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2024-06-13 |
| Est. Completion | 2025-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06441201
The ClinicalTrials.gov registry entry for NCT06441201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulse flowmeter is the first listed.
NCT06441201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06441201 about?
NCT06441201 is a clinical study titled "Acute Gastrointestinal Bleeding Peripheral Pulse Volume Changes". The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.
What is the current status of trial NCT06441201?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2024-06-13. Estimated completion is 2025-09-22.
What interventions are being tested in trial NCT06441201?
The interventions under investigation include: Pulse flowmeter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06441201?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.